Some features may not work as expected in this browser. For the full NewsNow experience, please consider updating your browser or trying a different device. Some features may not work as expected.
Please consider updating your browser or device.

Home
Hot Topics
Australia
World
Sport
Business
Entertainment
Science
Technology
Lifestyle

Novartis
Pharmaceuticals
GSK
AstraZeneca
Johnson and Johnson
AbbVie
Roche
Pfizer
Sanofi
Topics

Advertisement

Advertisement

Novartis

Share

Top Latest Popular

Yesterday

Stay Ahead of the Game With Novartis (NVS) Q3 Earnings: Wall Street's Insights on Key Metrics Zacks 15:24 Thu, 22 Oct

Wednesday

Novartis receives European Commission approval for Cosentyx® in polymyalgia rheumatica (PMR) Novartis (Press Release) 16:15 Wed, 21 Oct

Genentech, Novartis, Regeneron Shed False Claims Kickback Suit Bloomberg Law 13:53 Wed, 21 Oct

Advertisement

Advertisement

Novartis ranks #19 in TIME and Statista’s World’s Best Companies 2026 Novartis (Press Release) 08:06 Wed, 21 Oct

Genentech, Novartis Sue Amneal Over Bid To Sell Xolair Copy Law360 01:04 Wed, 21 Oct

Tuesday

LARK berät MorphoSys im Zusammenhang mit der Squeeze-Out-Hauptversammlung Chambers and Partners 09:01 Tue, 20 Oct

LARK berät MorphoSys im Zusammenhang mit dem öffentlichen Übernahmeangebot von Novartis Chambers and Partners 08:51 Tue, 20 Oct

Monday

Genentech, Novartis Say Amneal Infringed Allergy Drug Patents Bloomberg Law 21:57 Mon, 19 Oct

Sunday

Novartis abandons Fabhalta trial in lupus nephritis pharmaphorum 21:02 Sun, 18 Oct

In the last month

Women see five or six doctors to figure out menopause symptoms. A top Novartis exec says AI could finally connect the dots Fortune 19:50 Fri, 16 Oct

Genentech Wins Judge's OK Of $18M Novartis Award Law360 03:31 Thu, 15 Oct

CAS and Novartis collaborate to advance access to reaction data and AI research Chemical & Engineering News 13:43 Wed, 14 Oct

MindWalk Holdings Corp. Strengthens Boston-Based Development Leadership as Pipeline Advances Toward Preclinical Efficacy Studies Business Wire (Press Release) 13:02 Wed, 14 Oct

Community health takes a village: Screening in the barber’s chair Novartis (Press Release) 10:38 Tue, 13 Oct

Advertisement

Novartis inks $7.8 billion mRNA deal with Chinese company Abogen IAM 10:48 Mon, 12 Oct

Rhapsido Becomes First FDA-Approved Treatment for Hives Triggered by Scratching, but Fewer Than a Third Fully Cleared Medical Daily 18:46 Sat, 10 Oct

District Court Dismisses Entresto® Antitrust Suit, Holding Drug-Product Patent Properly Listed in Orange Book JD Supra 20:54 Fri, 09 Oct

Novartis achieves Tier 1 in the 2026 CCLA Corporate Mental Health Benchmark Novartis (Press Release) 19:04 Thu, 08 Oct

Investor alert: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Novartis AG - NVS PR Newswire (Press Release) 15:23 Thu, 08 Oct

Novartis Wins FDA Approval For First Symptomatic Dermographism Treatment RTT News 11:05 Thu, 08 Oct

Rhapsido is first drug cleared for chronic hives disorder SD pharmaphorum 20:36 Wed, 07 Oct

Novartis Rhapsido® (remibrutinib) receives FDA approval as first treatment for symptomatic dermographism (SD), expanding its use beyond chronic spontaneous urticaria (CSU) Novartis (Press Release) 16:57 Wed, 07 Oct

Novartis (SWX:NOVN) Could Be 7% Undervalued On Its Growth Narrative Simply Wall St 16:07 Wed, 07 Oct

Rivercell Launches With $25 Million to Build Data Platforms and AI Models That Predict How Human Cells Respond to Treatment Business Wire (Press Release) 14:02 Wed, 07 Oct

Novartis advances multiple sclerosis innovation with late-breaking remibrutinib and broad portfolio data at MSToronto2026 Novartis (Press Release) 12:13 Wed, 07 Oct

Novartis Sues Apotex Over Mekinist Copies, Tafinlar Drug Combo Bloomberg Law 19:37 Tue, 06 Oct

Novartis Strengthens RNA Therapeutics Pipeline With $7.8B Abogen Deal Zacks 18:28 Mon, 05 Oct

Novartis signs deal worth up to $7.8bn for Abogen’s mRNA T-cell engager Manufacturing Chemist 12:23 Mon, 05 Oct

Novartis India share price jumps 10% | What lies ahead for the stock? Mint 06:27 Mon, 05 Oct

Novartis taps Abogen’s RNA platform in potential $7.8B deal BioWorld 21:38 Fri, 02 Oct

Novartis taps China's Abogen for autoimmunity TCE pharmaphorum 13:26 Fri, 02 Oct

Novartis bets on autoimmune BiTEs through $7.8bn Abogen deal Pharmaceutical Technology 11:27 Fri, 02 Oct

Novartis Eyes Platform Benefits In $7.2bn Abogen Alliance Scrip Pharma Intelligence 08:15 Fri, 02 Oct

Abogen Announces Licensing and Option Agreement with Novartis to Advance mRNA-Encoded T-Cell Engager and other potential RNA programs PR Newswire (Press Release) 05:44 Fri, 02 Oct

Novartis Can't Dodge Hedge Fund Trade Secrets Suit Law360 04:41 Fri, 02 Oct

Samsung Bioepis, Teva enter commercialization agreement on 6 biosimilar candidates The Korea Times 10:02 Thu, 01 Oct

An Open Letter from the Chairs of AstraZeneca, Boehringer Ingelheim, Chiesi Group, Ipsen, GSK, Novo, Novartis, Roche, and Sanofi Sanofi (Press Release) 06:13 Thu, 01 Oct

Community health takes a village: from Pulpit to Pew Novartis (Press Release) 09:37 Wed, 30 Sep

Cas announces collaboration with Novartis to advance AI-ready reaction informatics PR Newswire (Press Release) 13:02 Tue, 29 Sep

Cas gibt Zusammenarbeit mit Novartis bekannt, um die Ki-fähige Reaktionsinformatik voranzutreiben PR Newswire (Press Release) 13:02 Tue, 29 Sep

Advertisement

Advertisement

About our Novartis news

Latest news for Novartis, a global healthcare company based in Switzerland specialising in pharmaceuticals, including updates on company and product news.

NewsNow

Our Sites

NewsNow Nigeria

NewsNow România

NewsNow Australia

Work with us

Publisher Network

Dockside Online IDE

Legal

Subscription Terms

© Copyright 1997 - 2026 NewsNow Publishing Limited. All rights reserved.

Back to Business Pharmaceuticals
- Abbott Laboratories
- AbbVie AbbVie
- AstraZeneca
- Baxter Baxter
- Bayer Bayer
- Boehringer Ingelheim
- Bristol Myers Squibb
- Eli Lilly Eli Lilly
- Genentech Genentech
- GlaxoSmithKline
- Johnson and Johnson
- Merck and Co
- Novartis Novartis
- Novavax Novavax
- Novo Nordisk
- Pfizer Pfizer
- Roche Roche
- Sanofi Sanofi
- Takeda Takeda
- Teva Teva
- Zoetis Zoetis